Redefining
healthy aging.*
Fifty-five years of science, united around a single purpose — supporting aesthetic outcomes across the different layers of aging skin, for individual needs.
“Healthy aging” is used as Sinclair’s corporate purpose and brand positioning. It does not describe a therapeutic effect, clinical outcome, or performance claim of any individual product.
WHO WE ARE
Sinclair is a global medical aesthetics company. We design and deliver a wide portfolio of injectable and energy-based treatments — not as products to sell, but as solutions designed around tissue response, treatment precision and aesthetic outcomes.
OUR ORIGIN
Three pioneers.
One pharmaceutical foundation.
Sinclair was formed from the integration of three pioneers in aesthetics, built upon the foundation of a pharmaceutical company. We united decades of expertise across four disciplines — and pointed them all at the same problem.
01
Polymer Science
02
Multi-Energy Technologies
03
04
Bioengineering
Pharmaceutical R&D
OUR MISSION
We innovate to deliver the solution of choice for aging skin — technologies engineered for precision, personalization and performance across aesthetic treatment needs.
OUR VISION
To redefine the future of healthy aging* by establishing a new standard of personalized aesthetic care — aligned with each individual's skin and soft-tissue needs.
Precision. Personalization. Performance.
“Healthy aging” is used as Sinclair’s corporate purpose and brand positioning. It does not describe a therapeutic effect, clinical outcome, or performance claim of any individual product.
OUR FOUNDATION
One portfolio for the many dimensions of aging skin.
7
INJECTABLE BIOMATERIALS
THE SCIENCE BEHIND US
THE SCIENCE BEHIND US
2
NEUROTOXIN TECHNOLOGIES
Decades of science. Measured in proof.
The better we understand tissue response, the better we can design aesthetic technologies. Every laboratory, patent and publication contributes to our understanding of safety, performance and tissue response — and this is only the beginning.
Present in more than 55 countries.
“Healthy aging” is used as Sinclair’s corporate purpose and brand positioning. It does not describe a therapeutic effect, clinical outcome, or performance claim of any individual product.
Products and indications are subject to regulatory approval and may not be available in all markets; approved claims may vary by market.
7
ENERGY-BASED PLATFORMS
BY THE NUMBERS
8
100+
PUBLICATIONS
18
PATENT FAMILIES
GLOBAL LABS
10+
IN THE PIPELINE TO 2030
Through a direct presence in key global markets, complemented by a network of trusted distributors. Sinclair is a wholly owned subsidiary of Huadong Medicine Company Limited (Hangzhou, China) — also known as East China Pharmaceuticals, or HMC.
CAREERS